FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
Year: 1996
Type: other
Source: PubMed
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4300048429
